Tongling Jieya Biologic Technology Co Ltd

SZSE:301108

Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What is available on other sites you are seeing are mostly from the sell-side analysts.

What is Tongling Jieya Biologic Technology Co Ltd's stock price target?

Not Available

Tongling Jieya Biologic Technology Co Ltd doesn't have any price targets made by Wall Street professionals.

What is Tongling Jieya Biologic Technology Co Ltd's Revenue forecast?

Projected CAGR

52%

For the last 5 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's revenue is 15%. The projected CAGR for the next 1 year is 52%.

What is Tongling Jieya Biologic Technology Co Ltd's Operating Income forecast?

Projected CAGR

840%

For the last 5 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's operating income is -23%. The projected CAGR for the next 1 year is 840%.

What is Tongling Jieya Biologic Technology Co Ltd's Net Income forecast?

Projected CAGR

1 033%

For the last 5 years the compound annual growth rate for Tongling Jieya Biologic Technology Co Ltd's net income is -22%. The projected CAGR for the next 1 year is 1 033%.